Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma
Clinical trial NCT07355699 · RECRUITING
Trial details
- NCT number
- NCT07355699
- Sponsor
- Beijing Tongren Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-25
- Primary completion
- 2027-09-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.